Amityville-based Hi-Tech Pharmacal headquarters on Sept. 10, 2012.

Amityville-based Hi-Tech Pharmacal headquarters on Sept. 10, 2012. Credit: Steve Pfost

Hi-Tech Pharmacal Co. on Thursday announced federal approval of a generic liquid drug used to treat inflammation and eye pain after cataract surgery.

The Amityville-based drugmaker said the Food and Drug Administration had approved Bromfenac Ophthalmic Solution, 0.09% (once-a-day), a generic alternative to Bromday Ophthalmic Solution, 0.09%, made by ISTA Pharmaceuticals Inc. in California.

Hi-Tech said it “plans to launch the product immediately.”

The company also in the midst of being purchased by Akorn Inc. of Illinois for $640 million in cash.

On the latest episode of "Sarra Sounds Off," Newsday's Gregg Sarra and Matt Lindsay take a look top boys and girls basketball players on Long Island. Credit: Newsday

Sarra Sounds Off, Ep. 15: LI's top basketball players On the latest episode of "Sarra Sounds Off," Newsday's Gregg Sarra and Matt Lindsay take a look top boys and girls basketball players on Long Island.

On the latest episode of "Sarra Sounds Off," Newsday's Gregg Sarra and Matt Lindsay take a look top boys and girls basketball players on Long Island. Credit: Newsday

Sarra Sounds Off, Ep. 15: LI's top basketball players On the latest episode of "Sarra Sounds Off," Newsday's Gregg Sarra and Matt Lindsay take a look top boys and girls basketball players on Long Island.

SUBSCRIBE

Unlimited Digital AccessOnly 25¢for 6 months

ACT NOWSALE ENDS SOON | CANCEL ANYTIME